MedPath

Study on the mechanism of modified Shaogan Fuzi decoction on intestinal mucosal immune homeostasis in RA Cold Syndrome

Not Applicable
Recruiting
Conditions
rheumatoid arthritis
Registration Number
ITMCTR2100005071
Lead Sponsor
DongFang Hospital of Beijing University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the above RA classification criteria;
2. Meet the diagnostic criteria of TCM syndromes;
3. Meet the criteria for judging the disease: DAS28 > 3.2 (active stage);
4. Aged from 18 to 70 years;
5. Not drink yogurt for nearly 1 week;
6. Not take antibiotics in the past three months;
7. Signed informed consent.

Exclusion Criteria

1. Patients with inflammatory bowel disease, irritable bowel syndrome, persistent, transmissible gastroenteritis, colitis or gastritis;
2. Patients with cardiovascular, cerebrovascular, pulmonary, liver, kidney and hematopoietic system diseases and psychosis;
3. Patients with other rheumatic diseases such as systemic lupus erythematosus, Sjogren's syndrome, etc;
4. Positive human chorionic gonadotropin test;
5. Lactation period.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
zonulin;T help 17 cells;nuclear factor-kappa Bp65;Proportion of fecal cocci and bacilli;D-LA;diamine oxidase;Fecal PH value;Regulatory cells;myeloid differentiation factor 88;Toll-like receptor 4;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath